206 related articles for article (PubMed ID: 16581776)
1. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of CK2alpha and alpha' paralogues and their derived holoenzymes: evidence for the existence of a heterotrimeric CK2alpha'-holoenzyme forming trimeric complexes.
Olsen BB; Rasmussen T; Niefind K; Issinger OG
Mol Cell Biochem; 2008 Sep; 316(1-2):37-47. PubMed ID: 18574672
[TBL] [Abstract][Full Text] [Related]
3. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
4. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.
Turowec JP; Vilk G; Gabriel M; Litchfield DW
Oncotarget; 2013 Apr; 4(4):560-71. PubMed ID: 23599180
[TBL] [Abstract][Full Text] [Related]
7. CK2 phosphorylation of Pdx-1 regulates its transcription factor activity.
Meng R; Al-Quobaili F; Müller I; Götz C; Thiel G; Montenarh M
Cell Mol Life Sci; 2010 Jul; 67(14):2481-9. PubMed ID: 20339896
[TBL] [Abstract][Full Text] [Related]
8. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
Ahmad KA; Wang G; Ahmed K
Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
[TBL] [Abstract][Full Text] [Related]
9. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
Padmanabhan A; Gosc EB; Bieberich CJ
J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
[TBL] [Abstract][Full Text] [Related]
11. A N-terminally deleted form of the CK2α' catalytic subunit is sufficient to support cell viability.
Borgo C; D'Amore C; Cesaro L; Itami K; Hirota T; Salvi M; Pinna LA
Biochem Biophys Res Commun; 2020 Oct; 531(3):409-415. PubMed ID: 32800562
[TBL] [Abstract][Full Text] [Related]
12. Enhancing chemosensitivity to gemcitabine via RNA interference targeting the catalytic subunits of protein kinase CK2 in human pancreatic cancer cells.
Kreutzer JN; Ruzzene M; Guerra B
BMC Cancer; 2010 Aug; 10():440. PubMed ID: 20718998
[TBL] [Abstract][Full Text] [Related]
13. CK2 kinase activity but not its binding to CK2 promoter regions is implicated in the regulation of CK2α and CK2β gene expressions.
Lupp S; Gumhold C; Ampofo E; Montenarh M; Rother K
Mol Cell Biochem; 2013 Dec; 384(1-2):71-82. PubMed ID: 23963994
[TBL] [Abstract][Full Text] [Related]
14. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
Bowen C; Ostrowski MC; Leone G; Gelmann EP
Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
[No Abstract] [Full Text] [Related]
15. Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms.
Vilk G; Saulnier RB; St Pierre R; Litchfield DW
J Biol Chem; 1999 May; 274(20):14406-14. PubMed ID: 10318865
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012
[TBL] [Abstract][Full Text] [Related]
17. NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation.
Muhlbradt E; Asatiani E; Ortner E; Wang A; Gelmann EP
Cancer Res; 2009 Mar; 69(6):2615-22. PubMed ID: 19258508
[TBL] [Abstract][Full Text] [Related]
18. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of the CK2alpha'-based holoenzyme, an isozyme of CK2alpha: a comparative analysis.
Olsen BB; Boldyreff B; Niefind K; Issinger OG
Protein Expr Purif; 2006 Jun; 47(2):651-61. PubMed ID: 16442308
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.
Schneider CC; Götz C; Hessenauer A; Günther J; Kartarius S; Montenarh M
Mol Cell Biochem; 2011 Oct; 356(1-2):177-84. PubMed ID: 21750987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
